Peter Kitz

home / authors / peter-kitz

Peter Kitz is vice-president, Global Pharmaceutical Quality, Bristol-Myers Squibb.

Articles

The GMP/GDP Inspections Landscape—Part II: Considerations and Opportunities

Stephan Rönninger;Johanna Berberich;Peter Kitz;Véronique Davoust;Andreas Pfenninger

February 2nd 2017

The authors look at challenges and considerations to continuously improve inspection efficiency.

The GMP/GDP Inspection Landscape—Part I: Data

Stephan Rönninger;Johanna Berberich;Peter Kitz;Véronique Davoust;Andreas Pfenninger

January 2nd 2017

The European Federation of Pharmaceutical Industries and Associations (EFPIA) has conducted an annual survey of GMP/GDP inspections at sites and affiliates among its member companies from 2003 until the present time. This article describes findings of the EFPIA annual survey of site inspections among its member companies.